OpiCalc Logo

OpiCalc

--- Clinical Tools

Logo
OpiCalc
BPI (Brief)COMMCPOTDIRE ScoreFLACC / NIPSMME/MED CalcORT-RPAINADPEG ScoreVAS/NRS ScaleWidespread Pain Index

Clinical Evidence and Methodology

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

When to Use

  • Used clinically by primary care and pain specialists to justify the initiation or continuation of long-term opioid therapy.
  • Best applied when considering placing a patient with chronic non-cancer pain on a continuous opioid contract.
CLINICAL INSIGHT

How it Works

The 4 Core Dimensions

  • D (Diagnosis): Validates the anatomical/pathological severity of the pain generator.
  • I (Intractability): Ensures non-opioid, less risky modalities have been exhausted.
  • R (Risk): A multimodal check of reliability, psychological resilience, and addiction risk.
  • E (Efficacy): Determines if opioids actually improve the functional baseline without requiring constant upward titration.
CLINICAL INSIGHT

Practical Pearls

Holistic View Focus

  • The DIRE score uniquely incorporates "Social Support" and "Reliability", recognizing that opioid management requires a stable external environment.
  • Patients with a score below 14 should generally be treated with interventional procedures (injections/blocks), physical therapy, and non-opioid medications rather than chronic opioids, due to an overwhelmingly high risk of therapy failure.
CLINICAL INSIGHT

Next Steps

Scoring Interpretation

  • Score 7 - 13: Not a candidate for long-term opioid management. Failure or addiction is highly likely.
  • Score 14 - 21: Good candidate. Favorable prognosis for safe and effective long-term therapy.

DIRE Score

D = Diagnosis

Is the condition objectively capable of causing severe pain?

I = Intractability

Have other treatments failed?

R = Risk (4 Sub-Domains)

Assessing psychosocial and chemical stability.

E = Efficacy

Has the patient previously responded well to opioids without escalating dose?

Total DIRE Score

0/ 21
Not a Candidate

Opioid adherence and efficacy are highly unlikely.